Abstract The two most extensively studied cannabinoids, cannabidiol (CBD) and delta‐9‐tetrahydrocannabinol (THC), are used for myriad conditions. THC is predominantly…
Abstract Introduction: Chronic kidney disease (CKD) affects approximately 10% of the global population and is associated with a large symptom…
Abstract Background: Tetrahydrocannabivarin (THCV) is a phytocannabinoid commonly found in cannabis with potential pharmacological properties; however, its post-acute pharmacokinetics (PK)…
Abstract Objective: This study aimed to develop a quantitative analytical method for the simultaneous determination of cannabidiol (CBD) and melatonin…
Abstract Industrial hemp biomass, the low Δ9-tetrahydrocannabinol variety of Cannabis sativa, has been identified as a potential feed for ruminants.…
Abstract Background: Cannabinoids such as cannabidiol (CBD) exhibit anti-inflammatory properties and have the potential to act as a therapeutic following…
Abstract Purpose: Cannabidiol (CBD) is a promising therapeutic drug with low addictive potential and a favorable safety profile. However, CBD…
Abstract Cannabidiol (CBD) is a natural phytochemical agent and one of the most abundant found in Cannabis sativa. It is…
Abstract Most repurposed drugs have proved ineffective for treating COVID-19. We evaluated median effective and toxic concentrations (EC50, CC50) of…
Abstract The pharmacokinetics and tolerability of cannabinoids and their metabolites were determined in eight horses after enteral administration of a…